In this article we report the use of these Hsp90 inhibitors in pheochromocytoma, evaluating cellular activity in vitro and efficacy in two metastatic animal models of the disease [22]. This evidence concerns the gene HSP90AB1 and hereditary pheochromocytoma-paraganglioma.